Global Oncology Anti-Cancer Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-03-20
- Report ID: 72762
- Pages: 124
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearchs analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Oncology Anti-Cancer Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Oncology Anti-Cancer Drugs Market byPrudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Oncology Anti-Cancer Drugs Market
Amgen
AstraZeneca
Roche Diagnostics
GlaxoSmithKline
Merck
Novartis
AbbVie
Sanofi
EIMC United Pharmaceuticals
Actavis
...
Major Type of Oncology Anti-Cancer Drugs Covered inPrudent Markets report:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Application Segments Covered inPrudent Markets Market
Blood Cancer (Leukaemia)
Breast Cancer
Gastrointestinal Cancer
Respiratory/Lung Cancer
Skin Cancer
Other Cancers
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Oncology Anti-Cancer Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Chemotherapy -Product Introduction and Major Manufacturers
1.1.2 Targeted Therapy -Product Introduction and Major Manufacturers
1.1.3 Immunotherapy (Biologic Therapy) -Product Introduction and Major Manufacturers
1.1.4 Hormonal Therapy -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Oncology Anti-Cancer Drugs Status and Prospect (2015-2026)
2.1.1 China Oncology Anti-Cancer Drugs Market Size and Growth Rate (2015-2026)
2.1.2 China Oncology Anti-Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Oncology Anti-Cancer Drugs Status and Prospect (2015-2026)
2.2.1 EU Oncology Anti-Cancer Drugs Market Size and Growth Rate (2015-2026)
2.2.2 EU Oncology Anti-Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Oncology Anti-Cancer Drugs Status and Prospect (2015-2026)
2.3.1 USA Oncology Anti-Cancer Drugs Market Size and Growth Rate (2015-2026)
2.3.2 USA Oncology Anti-Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Oncology Anti-Cancer Drugs Status and Prospect (2015-2026)
2.4.1 Japan Oncology Anti-Cancer Drugs Market Size and Growth Rate (2015-2026)
2.4.2 Japan Oncology Anti-Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Oncology Anti-Cancer Drugs Status and Prospect (2015-2026)
2.5.1 India Oncology Anti-Cancer Drugs Market Size and Growth Rate (2015-2026)
2.5.2 India Oncology Anti-Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Oncology Anti-Cancer Drugs Status and Prospect (2015-2026)
2.6.1 Southeast Asia Oncology Anti-Cancer Drugs Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Oncology Anti-Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Oncology Anti-Cancer Drugs Status and Prospect (2015-2026)
2.7.1 South America Oncology Anti-Cancer Drugs Market Size and Growth Rate (2015-2026)
2.7.2 South America Oncology Anti-Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Oncology Anti-Cancer Drugs Status and Prospect (2015-2026)
2.8.1 Oncology Anti-Cancer Drugs Market Size and Growth Rate (2015-2026)
2.8.2 Oncology Anti-Cancer Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Oncology Anti-Cancer Drugs Market Assessment by Segment
3.1 Global Oncology Anti-Cancer Drugs Capacity and Growth Rate
3.2 Global Oncology Anti-Cancer Drugs Sales by Type
3.3 Global Oncology Anti-Cancer Drugs Sales Revenue by Type
3.4 Global Oncology Anti-Cancer Drugs Consumption by Application
4 Global Oncology Anti-Cancer Drugs Market Assessment by Regions
4.1 Global Oncology Anti-Cancer Drugs Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Oncology Anti-Cancer Drugs Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Oncology Anti-Cancer Drugs Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Oncology Anti-Cancer Drugs Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Oncology Anti-Cancer Drugs Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Oncology Anti-Cancer Drugs Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Oncology Anti-Cancer Drugs Sales Market Share of Manufacturers (2019-2020)
6.3 Global Oncology Anti-Cancer Drugs Sales Revenue Market Share of Manufacturers (2019-2020)
7 Oncology Anti-Cancer Drugs Competitive Analysis
7.1 Amgen
7.1.1 Amgen Company Profiles
7.1.2 Amgen Product Introduction
7.1.3 Amgen Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 AstraZeneca
7.2.1 AstraZeneca Company Profiles
7.2.2 AstraZeneca Product Introduction
7.2.3 AstraZeneca Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Company Profiles
7.3.2 Roche Diagnostics Product Introduction
7.3.3 Roche Diagnostics Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Profiles
7.4.2 GlaxoSmithKline Product Introduction
7.4.3 GlaxoSmithKline Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Merck
7.5.1 Merck Company Profiles
7.5.2 Merck Product Introduction
7.5.3 Merck Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Novartis
7.6.1 Novartis Company Profiles
7.6.2 Novartis Product Introduction
7.6.3 Novartis Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 AbbVie
7.7.1 AbbVie Company Profiles
7.7.2 AbbVie Product Introduction
7.7.3 AbbVie Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Sanofi
7.8.1 Sanofi Company Profiles
7.8.2 Sanofi Product Introduction
7.8.3 Sanofi Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 EIMC United Pharmaceuticals
7.9.1 EIMC United Pharmaceuticals Company Profiles
7.9.2 EIMC United Pharmaceuticals Product Introduction
7.9.3 EIMC United Pharmaceuticals Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Actavis
7.10.1 Actavis Company Profiles
7.10.2 Actavis Product Introduction
7.10.3 Actavis Oncology Anti-Cancer Drugs Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
